BCA-1 (Protein|Antibody|cDNA Clone|ELISA Kit)

All BCA-1 reagents are produced in house and quality controlled, including 3 BCA-1 Antibody, 52 BCA-1 Gene, 3 BCA-1 Protein, 2 BCA-1 qPCR. All BCA-1 reagents are ready to use.

Recombinant BCA-1 proteins are expressed by E. coli with fusion tags as Native, N-His.

BCA-1 antibodies are validated with different applications, which are ELISA.

BCA-1 cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each BCA-1 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

BCA-1 Protein (3)

Species

BCA-1 Protein, Cynomolgus, Recombinant (His Tag)

90021-C07E

Expression host: E. coli

Cynomolgus BCA-1 / CXCL13 Protein 12738

BCA-1 Protein, Human, Recombinant

10621-HNAE

Expression host: E. coli

Human BCA-1 / CXCL13 Protein 15084

BCA-1 Protein, Canine, Recombinant (His Tag)

70057-D07E

Expression host: E. coli

Canine BCA-1 / CXCL13 Protein 12251
Go

BCA-1 Antibody (3)

Application
Clonality
Host

Anti-BCA-1 Antibody

70057-RP01

Specificity: Canine

Application: ELISA

Clonality: PAb

Anti-BCA-1 Antibody

70057-T16

Specificity: Canine

Application: ELISA

Clonality: PAb

Anti-BCA-1 Antibody

70057-MM13

Specificity: Canine

Application: ELISA

Clonality: MAb

Go

BCA-1 cDNA Clone (52)

Human
Mouse
Canine
Rhesus

BCA-1 qPCR Primer (2)

The chemokine CXCL13, also known as BCA-1 (B-cell-attracting chemokine-1) or BLC (B-lymphocyte chemoattractant), which belongs to the CXC chemokine family. CXCL13 and its receptor CXCR5 control the organization of B cells within follicles of lymphoid tissues. CXCL13 is known to dictate homing and motility of B cells in lymphoid tissue and has been implicated in the formation of ectopic lymphoid tissue in chronic inflammation. It involves in B-cell compartmental homing within secondary lymphoid organs and recently implicated in the pathogenesis of inflammatory and malignant lymphocyte-mediated diseases. In Primary central nervous system lymphoma (PCNSL), expression of BCA-1 by malignant lymphocytes and vascular endothelium may influence tumor development and localization to central nervous system (CNS). In T-lymphocytes, CXCL13 expression is thought to reflect a germinal center origin of the T-cell. CXCL13 expression may also provide an additional useful tool for the diagnosis of Angioimmunoblastic T-cell lymphoma (AITL).
Protein
Antibody
Gene
qPCR
Close